The prognostic model constructed in this study incorporated 15 tumor-cell-specific genes (SRSF7, NQO1, APCS, NUPR1, SCARB1, DAB2, ANG, PPP2R1B, C1S, SERPINE1, GADD45G, ITIH1, PDK4, HSP90AA1, SAT1) associated with progression and treatment resistance. This evidence concerns the gene C1S and neoplasm.